Delzicol and Pregnancy

When Delzicol (mesalamine) was given to pregnant animals, it did not appear to cause birth defects or other problems. As a result, it is generally considered safe to take this drug during pregnancy, although the full risks are currently unknown. This drug should only be prescribed to a pregnant woman if the benefits outweigh the risks.

 

Can Pregnant Women Take Delzicol?

Delzicol® (mesalamine) is probably safe for pregnant women. However, the full risks of taking this medicine during pregnancy are currently unknown.
 

What Is Pregnancy Category B?

The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Delzicol is classified as a pregnancy Category B medicine.
 
Pregnancy Category B is given to medicines that have not been studied in pregnant humans but do not appear to cause harm to the fetus in animal studies.
 
When given to pregnant rats and rabbits, Delzicol did not appear to cause any problems.
 
However, it is important to note that animals do not always respond to medicines in the same way that humans do; therefore, the full risks of using Delzicol during pregnancy are unknown. Delzicol should be given to a pregnant woman only if her healthcare provider believes that the benefits to the woman outweigh any possible risks to her unborn child.
 

Final Thoughts

If you are pregnant or thinking about becoming pregnant while taking Delzicol, let your healthcare provider know. He or she will consider both the benefits and risks before making a recommendation in your particular situation.
 
Pregnancy and Pain

Delzicol Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.